XML 18 R6.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Common Stock
Restricted Stock Units
Additional Paid-in Capital
Retained Earnings
Treasury Stock
Accumulated Other Comprehensive (Loss)/Income
Non-controlling interest in consolidated subsidiaries
Balance, beginning of period (in shares) at Dec. 31, 2021   56,849            
Balance, beginning of period at Dec. 31, 2021 $ 2,495,837 $ 57   $ 711,912 $ 1,829,532 $ (177) $ (54,207) $ 8,720
Treasury stock, beginning of period (in shares) at Dec. 31, 2021           20    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Restricted stock units vested (in shares)     193          
Equity withheld for employee taxes (in shares)   (67)            
Equity withheld for employee taxes (18,376)     (18,376)        
Stock-based compensation expense 22,702     22,702        
Exercise of stock options (in shares)   158            
Exercise of stock options 2,884     2,884        
Other comprehensive income (loss) (31,943)           (31,943)  
Purchase of subsidiary shares from noncontrolling interest (7,067)             (7,067)
Net income 89,719       89,719      
Balance, end of period (in shares) at Mar. 31, 2022   57,133            
Balance, end of period at Mar. 31, 2022 2,553,756 $ 57   719,122 1,919,251 $ (177) (86,150) 1,653
Treasury stock, end of period (in shares) at Mar. 31, 2022           20    
Balance, beginning of period (in shares) at Dec. 31, 2021   56,849            
Balance, beginning of period at Dec. 31, 2021 2,495,837 $ 57   711,912 1,829,532 $ (177) (54,207) 8,720
Treasury stock, beginning of period (in shares) at Dec. 31, 2021           20    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Other comprehensive income (loss) (22,150)              
Net income 108,323              
Balance, end of period (in shares) at Jun. 30, 2022   57,353            
Balance, end of period at Jun. 30, 2022 2,624,006 $ 57   760,975 1,937,855 $ (177) (76,357) 1,653
Treasury stock, end of period (in shares) at Jun. 30, 2022           20    
Balance, beginning of period (in shares) at Mar. 31, 2022   57,133            
Balance, beginning of period at Mar. 31, 2022 2,553,756 $ 57   719,122 1,919,251 $ (177) (86,150) 1,653
Treasury stock, beginning of period (in shares) at Mar. 31, 2022           20    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Restricted stock units vested (in shares)     24          
Equity withheld for employee taxes (in shares)   (6)            
Equity withheld for employee taxes (1,843)     (1,843)        
Stock-based compensation expense 24,902     24,902        
Exercise of stock options (in shares)   147            
Exercise of stock options 6,410     6,410        
Issuance of common stock from employee stock purchase plan (in shares)   55            
Issuance of common stock from employee stock purchase plan 12,384     12,384        
Other comprehensive income (loss) 9,793           9,793  
Net income 18,604       18,604      
Balance, end of period (in shares) at Jun. 30, 2022   57,353            
Balance, end of period at Jun. 30, 2022 $ 2,624,006 $ 57   760,975 1,937,855 $ (177) (76,357) 1,653
Treasury stock, end of period (in shares) at Jun. 30, 2022           20    
Balance, beginning of period (in shares) at Dec. 31, 2022 57,655 57,655            
Balance, beginning of period at Dec. 31, 2022 $ 3,003,010 $ 58   847,965 2,248,948 $ (118) (95,321) 1,478
Treasury stock, beginning of period (in shares) at Dec. 31, 2022           14    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Restricted stock units vested (in shares)     224          
Equity withheld for employee taxes (in shares)   (72)            
Equity withheld for employee taxes (20,501)     (20,501)        
Stock-based compensation expense 34,265     34,265        
Exercise of stock options (in shares)   71            
Exercise of stock options 2,525     2,525        
Repurchase of common stock (in shares)   (30)            
Repurchase of common stock (8,510)       (8,510)      
Other comprehensive income (loss) 17,361           17,361  
Net income 102,292       102,292      
Balance, end of period (in shares) at Mar. 31, 2023   57,848            
Balance, end of period at Mar. 31, 2023 $ 3,130,442 $ 58   864,254 2,342,730 $ (118) (77,960) 1,478
Treasury stock, end of period (in shares) at Mar. 31, 2023           14    
Balance, beginning of period (in shares) at Dec. 31, 2022 57,655 57,655            
Balance, beginning of period at Dec. 31, 2022 $ 3,003,010 $ 58   847,965 2,248,948 $ (118) (95,321) 1,478
Treasury stock, beginning of period (in shares) at Dec. 31, 2022           14    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Exercise of stock options (in shares) 241              
Other comprehensive income (loss) $ 23,236              
Net income $ 222,325              
Balance, end of period (in shares) at Jun. 30, 2023 57,955 57,955            
Balance, end of period at Jun. 30, 2023 $ 3,263,340 $ 58   913,580 2,421,326 $ (118) (72,085) 579
Treasury stock, end of period (in shares) at Jun. 30, 2023           14    
Balance, beginning of period (in shares) at Mar. 31, 2023   57,848            
Balance, beginning of period at Mar. 31, 2023 3,130,442 $ 58   864,254 2,342,730 $ (118) (77,960) 1,478
Treasury stock, beginning of period (in shares) at Mar. 31, 2023           14    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Restricted stock units vested (in shares)     76          
Equity withheld for employee taxes (in shares)   (21)            
Equity withheld for employee taxes (6,142)     (6,142)        
Stock-based compensation expense 32,449     32,449        
Exercise of stock options (in shares)   170            
Exercise of stock options 4,601     4,601        
Issuance of common stock from employee stock purchase plan (in shares)   77            
Issuance of common stock from employee stock purchase plan 18,466     18,466        
Repurchase of common stock (in shares)   (195)            
Repurchase of common stock (41,437)       (41,437)      
Other comprehensive income (loss) 5,875           5,875  
Purchase of subsidiary shares from noncontrolling interest (1,453)     (48)       (1,405)
Contributions to consolidated subsidiary from noncontrolling interest 506             506
Net income $ 120,033       120,033      
Balance, end of period (in shares) at Jun. 30, 2023 57,955 57,955            
Balance, end of period at Jun. 30, 2023 $ 3,263,340 $ 58   $ 913,580 $ 2,421,326 $ (118) $ (72,085) $ 579
Treasury stock, end of period (in shares) at Jun. 30, 2023           14